Re: Diabetes Forecast Magazine Poll
|
|
Mannkind
|
Jan 30, 2013 01:36PM
|
Re: Diabetes Drugs Market Will Reach $55.3bn in 2017, With Further Growth to 2023,
|
|
Mannkind
|
May 07, 2013 10:00AM
|
Re: Debt Burden Makes Horizon Pharma An Attractive Short
|
|
Mannkind
|
Jul 26, 2012 10:29AM
|
Re: David Kliff And Diabeticinvestor.com
|
1
|
Mannkind
|
Jun 17, 2013 02:23PM
|
Re: CREW Calls for DOJ Investigation Into Short-Seller Shkreli
|
1
|
Mannkind
|
Jul 09, 2012 06:53PM
|
Re: CREW Calls for DOJ Investigation Into Short-Seller Shkreli
|
|
Mannkind
|
Jul 09, 2012 11:47PM
|
Re: Cowen and Company
|
|
Mannkind
|
Feb 20, 2013 04:33PM
|
Re: Cowen and Company
|
|
Mannkind
|
Feb 20, 2013 05:07PM
|
Re: Cowen and Company
|
|
Mannkind
|
Feb 20, 2013 05:10PM
|
Re: Cowen and Company
|
2
|
Mannkind
|
Feb 20, 2013 06:14PM
|
Re: Couple of newbie questions. Please help!
|
|
Mannkind
|
May 15, 2013 12:03PM
|
Re: Could this recent weakness in share price
|
|
Mannkind
|
Oct 10, 2012 11:14AM
|
Re: Copy of Joe Springer Article - 5 Reasons MannKind Could Be The Best Performing S
|
|
Mannkind
|
Jun 22, 2013 11:11AM
|
Re: Copy of Joe Springer Article - 5 Reasons MannKind Could Be The Best Performing S
|
1
|
Mannkind
|
Jun 22, 2013 11:39AM
|
Re: Copy of Joe Springer Article - 5 Reasons MannKind Could Be The Best Performing S
|
|
Mannkind
|
Jun 22, 2013 01:04PM
|
Re: Copy of Joe Springer Article - 5 Reasons MannKind Could Be The Best Performing S
|
2
|
Mannkind
|
Jun 22, 2013 06:57PM
|
Re: Cool dig: read the comments!
|
|
Mannkind
|
Dec 31, 2012 10:25AM
|
Re: Congratulations MNKD
|
|
Mannkind
|
May 11, 2012 03:59PM
|
Re: Conflict of interest?
|
3
|
Mannkind
|
Aug 30, 2012 02:01PM
|
Re: Conflict of interest?
|
|
Mannkind
|
Aug 30, 2012 11:03AM
|